Open access
142
Views
6
CrossRef citations to date
0
Altmetric
Original Research
Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States
Gabriel Tremblay1 Purple Squirrel Economics, New York, NY, USACorrespondence[email protected]
, Qayyim Said2 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
, Anuja Nidumolu Roy2 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
, Beilei Cai2 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
, Shan Ashton Garib1 Purple Squirrel Economics, New York, NY, USA
, Jaclyn Hearnden1 Purple Squirrel Economics, New York, NY, USA
& Anna Forsythe1 Purple Squirrel Economics, New York, NY, USA
show all
Pages 673-681
|
Published online: 12 Nov 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.